Characteristics and Risk Factors of Thrombotic Complications in Patients With Iron Deficiency Anemia
- 27 July 2026
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 117 (5) , 1338-1346
Abstract
Background/Objective: Although thromboses in association with iron deficiency anemia (IDA) have been reported in several case reports, comprehensive studies investigating the incidence, characteristics, and risk factors of thrombosis in this population remain limited. Herein, we sought to characterize the clinical features of thrombosis occurring in IDA patients and to identify potential risk factors contributing to thrombosis development in this context. Methods: This retrospective study included 329 IDA patients and 150 healthy controls. Medical records were evaluated for CBC, iron profiles, and incidence of thrombosis. Inflammatory biomarkers were calculated from baseline CBC, including ratios of neutrophil‐to‐lymphocyte (NLR), monocyte‐to‐lymphocyte (MLR), platelet‐to‐lymphocyte (PLR), systemic inflammatory index (SII), systemic inflammatory response‐index (SIRI), and aggregate‐index of systemic inflammation (AISI). IDA patients were stratified based on thrombosis progression. Results: Among IDA patients, 62 patients (18.85%) developed post‐diagnosis thrombotic events (15.20% arterial and 3.65% venous), and the estimated 10‐year thrombotic event‐free survival rate was 73.56%. Arterial events were mostly ischemic heart diseases ( n = 29, 8.81%). IDA patients with thrombotic progression showed a significant increase in NLR, MLR, PLR, SII, AISI, and SIRI compared to healthy controls. IDA patients with thrombotic progression revealed significantly higher WBC counts, neutrophils, monocytes, NLP, MLR, AISI, SIRI, older age, and a prior history of thrombosis compared to IDA patients without thrombotic events. Multivariate logistic regression analysis unveiled that age, previous history of thrombosis, and leukocytosis were independent risk factors for thrombosis progression in IDA patients. Conclusion: The study characterizes thrombotic events in IDA patients and underpins evidence connecting systemic inflammation to thrombosis progression, highlighting the importance of effective management of this common disorder.Keywords
This publication has 22 references indexed in Scilit:
- The impact of wet cupping on haematological and inflammatory parameters in a sample of Jordanian team playersHeliyon, 2024
- Inflammatory Biomarkers Correlate with Time Evolution in Cerebral Venous ThrombosisJournal of Stroke and Cerebrovascular Diseases, 2021
- The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency AnemiaJAMA Network Open, 2020
- Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemiaAmerican Journal of Hematology, 2020
- Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysisThe American Journal of Emergency Medicine, 2020
- Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis?Experimental and Molecular Pathology, 2019
- Platelet‐neutrophil crosstalk and netosisHemaSphere, 2019
- How we diagnose and treat iron deficiency anemiaAmerican Journal of Hematology, 2015
- White blood cell count and mortality in patients with acute pulmonary embolismAmerican Journal of Hematology, 2013
- In vitro cytokine production in patients with iron deficiency anemiaClinical Immunology, 2004